The payroll solutions provider rolled out a centralized dashboard to unify payroll management across multiple clients, plus a benefits advisor for accountants.
A new analyst survey suggests that doctors are still prescribing Sarepta’s Elevidys, even after a series of deaths in certain populations marred the gene therapy’s record.
Merck, Eli Lilly and AstraZeneca have similarly suspended or outright canceled investments in the U.K. in the past week after a sizeable increase in a mandatory levy in the region.
The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between on-site and centralized manufacturing.
With Microsoft planning to end most support for Windows 10 in October, firms that have delayed their upgrades now face a significant challenge as the newest version may require some to replace their old devices.
The numbers look gaudy, but potential estate taxes and prohibitions on future strategies make the big retirement accounts much less appealing, two experts said.
The Internal Revenue Service has posted a draft version of Schedule 1-A, “Additional Deductions,” for Form 1040 that will be used next tax season when claiming new tax breaks.